// App-Quantinova.ai

783 : Comprehensive Profiling of Somatic Mutations Which Define Primary Disease and Relapse in Various Acute Leukemia Subtypes

Researchers

Presenter

  • Wen-Wen Chien

Principal Investigators

  • Tamara Alpermann

  • Ezhilarasi Chendamarai

  • Saravanan Ganesan

  • Daniel Nowak

  • Tsuyoshi Nakamaki

  • Norihiko Kawamata

  • Takayuki Ikezoe

  • Shirle

  • Kow Yin Kham

  • Jairo Matthews

  • Manoj Garg

  • Liu Lizhen

  • Meng Xuan

  • Lim Su Lin

  • Olga Blau

  • Steven M. Kornblau

  • Rui-yu Wang

  • Michael Andreeff

  • Shigeru Tomoyasu

  • Wolf-Karsten Hofmann

  • Norimichi Hattori

  • Allen Yeoh

  • Sun Qiaoyang

  • Henry Yang

  • Yasunobu Nagata

  • Kenichi Yoshida

  • Masashi Sanada

  • Yusuke Okuno

Medical Centers

  • Division of Hematology/Oncology, Department of Internal Medicine, Linkou Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan

  • Munich Leukemia Laboratory, Munich, Germany.

  • Department of Medicine, National University Hospital, Singapore, Singapore

  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan

  • Cancer Genomics Project, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

  • Department of Hematology, Oncology and Tumor Immunology, Charite University Medicine, Campus Benjamin Franklin, Berlin, Germany

  • Hematology and Respiratory Medicine, Kochi Medical School, Kochi University, Nankoku, Japan

  • Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore

  • Department of CSCR/Haematology, Christian Medical College, Vellore, India

  • Section of Molecular Hematology & Department of Hematology / Oncology, Cedars Cinai Medical Center, Los Angeles, CA, USA,

  • III. Medizinische Klinik, Hamatologie und Onkologie, Universitatsmedizin Mannheim, Mannheim, Germany

  • Department of Hematology and Oncology, University Hospital, Rostock, Germany

Locations

  • Taiwan

  • Japan

  • Singapore

  • Germany

  • United States

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Acute lymphoblastic leukemia

  • Acute Leukemia

Biomarkers

  • Promyelocytic Leukemia

  • DNA methyltransferase 3 alpha

  • ETV6-RUNX1

  • Isocitrate dehydrogenase 1

  • KIT Proto-Oncogene, Receptor Tyrosine Kinase

  • Tet methylcytosine dioxygenase 2

  • WT1 Transcription Factor

Drug/Treatment

  • T-15

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved